Mood and Cognitive Outcome After Heart Transplantation (the MOODHEART Study)
Nevropsykiatri og Hjertetransplantasjon
Nevropsykiatri og Hjertetransplantasjon
Sponsor study identifier
observational
74
1 country
1
Study Start
December 2013
Actual (reported)Primary Completion
November 2015
Actual (reported)Study Completion
November 2015
Actual (reported)The investigators aim at characterizing neuropsychiatric consequences of heart transplantation (HTX) and at assessing the impact of depressive symptoms after HTX on mortality and cardiac allograft vasculopathy (CAV).
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
November 2015
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
December 2013
Actual (reported)December 2, 2013
Actual (reported)January 14, 2014
Actual (reported)November 2015
Actual (reported)November 2015
Actual (reported)Psychiatric morbidity
Psychiatric diagnoses by clinician and self-rapport
At time of enrollment
Cognitive function
Neuropsychological assessment
At time of enrollment
All cause mortality
14 and 3 years respectively
Cardiac allograft vasculopathy
14 and 3 years respectively
Cerebral pathology
At time of enrollment
Surviving participants from a former study called 'Psykosomale faktorer hos pasienter med hjertesvikt og hos hjertetransplanterte'
Surviving participants, included at the Norwegian centre, from a study called 'Scandinavian Heart Transplant Everolimus De Novo Study with Early Calcineurin Inhibitor Avoidance (SCHEDULE)' (NCT01266148)
Surviving participants from two former studies
Oslo University Hospital
Oslo, 0424, Norway
Serum and plasma
Ira R. Hebold Haraldsen, MD/dr philos
Oslo University Hospital
74 participants (actual enrollment reported by the registry).
First Submitted
December 2, 2013
First Posted
January 14, 2014
Study Start
December 2013
Actual (reported)Southend Imaging Study
Contact the study team to confirm eligibility.
Primary Completion
November 2015
Actual (reported)Study Completion
November 2015
Actual (reported)Last Updated
August 9, 2021
Record last verified: 2021-08
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: